SPY339.39-6.39 -1.85%
DIA277.00-6.34 -2.24%
IXIC11,358.94-189.35 -1.64%

Wells Fargo Downgrades Iovance Biotherapeutics to Equal-Weight, Lowers Price Target to $29

Wells Fargo downgrades Iovance Biotherapeutics (NASDAQ:IOVA) from Overweight to Equal-Weight and lowers the price target from $49 to $29.

· 10/06/2020 08:23
Wells Fargo downgrades Iovance Biotherapeutics (NASDAQ:IOVA) from Overweight to Equal-Weight and lowers the price target from $49 to $29.